28057660|t|Protocol for intraoperative assessment of the human cerebrovascular glycocalyx
28057660|a|Adequate functioning of the blood-brain barrier (BBB) is important for brain homoeostasis and normal neuronal function. Disruption of the BBB has been described in several neurological diseases. Recent reports suggest that an increased permeability of the BBB also contributes to increased seizure susceptibility in patients with epilepsy. The endothelial glycocalyx is coating the luminal side of the endothelium and can be considered as the first barrier of the BBB. We hypothesise that an altered glycocalyx thickness plays a role in the aetiology of temporal lobe epilepsy (TLE), the most common type of epilepsy. Here, we propose a protocol that allows intraoperative assessment of the cerebrovascular glycocalyx thickness in patients with TLE and assess whether its thickness is decreased in patients with TLE when compared with controls. This protocol is designed as a prospective observational case-control study in patients who undergo resective brain surgery as treatment for TLE. Control subjects are patients without a history of epileptic seizures, who undergo a craniotomy or burr hole surgery for other indications. Intraoperative glycocalyx thickness measurements of sublingual, cortical and hippocampal microcirculation are performed by video microscopy using sidestream dark-field imaging. Demographic details, seizure characteristics, epilepsy risk factors, intraoperative haemodynamic parameters and histopathological evaluation are additionally recorded. This protocol has been ethically approved by the local medical ethical committee (ID: NL51594.068.14) and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Informed consent is obtained before study enrolment and only coded data will be stored in a secured database, enabling an audit trail. Results will be submitted to international peer-reviewed journals and presented at international conferences. NTR5568.
28057660	0	8	Protocol	T170	UMLS:C2348563
28057660	28	38	assessment	T062	UMLS:C0936012
28057660	46	51	human	T204	UMLS:C0086418
28057660	68	78	glycocalyx	T017	UMLS:C0061622
28057660	107	126	blood-brain barrier	T038	UMLS:C1305865
28057660	128	131	BBB	T038	UMLS:C1305865
28057660	150	155	brain	T017	UMLS:C0006104
28057660	156	168	homoeostasis	T038	UMLS:C0019868
28057660	180	188	neuronal	T017	UMLS:C0027882
28057660	189	197	function	T038	UMLS:C0007613
28057660	217	220	BBB	T038	UMLS:C1305865
28057660	251	272	neurological diseases	T038	UMLS:C0027765
28057660	281	288	reports	T170	UMLS:C0684224
28057660	315	327	permeability	T038	UMLS:C0007605
28057660	335	338	BBB	T017	UMLS:C0005854
28057660	369	376	seizure	T033	UMLS:C0036572
28057660	377	391	susceptibility	T201	UMLS:C0012655
28057660	409	417	epilepsy	T038	UMLS:C0014544
28057660	423	434	endothelial	T017	UMLS:C0014257
28057660	435	445	glycocalyx	T017	UMLS:C0061622
28057660	461	473	luminal side	T082	UMLS:C0524462
28057660	481	492	endothelium	T017	UMLS:C0014257
28057660	543	546	BBB	T038	UMLS:C1305865
28057660	579	589	glycocalyx	T017	UMLS:C0061622
28057660	633	655	temporal lobe epilepsy	T038	UMLS:C0014556
28057660	657	660	TLE	T038	UMLS:C0014556
28057660	687	695	epilepsy	T038	UMLS:C0014544
28057660	716	724	protocol	T170	UMLS:C2348563
28057660	752	762	assessment	T062	UMLS:C0936012
28057660	786	796	glycocalyx	T017	UMLS:C0061622
28057660	824	827	TLE	T038	UMLS:C0014556
28057660	891	894	TLE	T038	UMLS:C0014556
28057660	929	937	protocol	T170	UMLS:C2348563
28057660	955	999	prospective observational case-control study	T062	UMLS:C0007328
28057660	1024	1047	resective brain surgery	T058	UMLS:C0195960
28057660	1051	1060	treatment	T058	UMLS:C0087111
28057660	1065	1068	TLE	T038	UMLS:C0014556
28057660	1110	1117	history	T033	UMLS:C1287400
28057660	1121	1139	epileptic seizures	T038	UMLS:C0014544
28057660	1155	1165	craniotomy	T058	UMLS:C0010280
28057660	1169	1186	burr hole surgery	T058	UMLS:C0040836
28057660	1225	1235	glycocalyx	T017	UMLS:C0061622
28057660	1262	1272	sublingual	T082	UMLS:C0026638
28057660	1274	1282	cortical	T017	UMLS:C0007776
28057660	1287	1298	hippocampal	T017	UMLS:C0019564
28057660	1299	1315	microcirculation	T038	UMLS:C0025962
28057660	1333	1349	video microscopy	T058	UMLS:C0242940
28057660	1356	1385	sidestream dark-field imaging	T058	UMLS:C0011923
28057660	1408	1415	seizure	T033	UMLS:C0036572
28057660	1442	1454	risk factors	T033	UMLS:C0035648
28057660	1471	1483	haemodynamic	T038	UMLS:C0019010
28057660	1517	1527	evaluation	T062	UMLS:C0936012
28057660	1560	1568	protocol	T170	UMLS:C2348563
28057660	1604	1635	local medical ethical committee	T097	UMLS:C0085546
28057660	1679	1743	Declaration of Helsinki and principles of Good Clinical Practice	T170	UMLS:C2986419
28057660	1781	1786	study	T062	UMLS:C2603343
28057660	1845	1853	database	T170	UMLS:C0242356
28057660	1909	1945	international peer-reviewed journals	T170	UMLS:C2985503